Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

New Stock Coverage: T-Mobile Gets Lukewarm Reception

By

Wall Street ratings agencies set the tone for today's stock market.

PrintPRINT
The Dow (^DJI) snapped a four-session winning streak, with free markets enduring an especially inauspicious time of it on the sort of May Day only Fidel Castro could love. April showers, it turned out, only soaked investors on the first day of the month, although flowers were not far to be found if you looked hard enough. (Indeed even Cuba's communist icon was once spotted laying a wreath at the cathedral of capitalism.)

A fat lot of good it did the Knicks, but Madison Square Garden (MSG) was in full bloom in hitting an all-time high. Longtime T-Mobile USA (TMUS) mouthpiece Catherine-Zeta-Jones, who once starred in a show called The Darling Buds Of May, will have enjoyed an analyst inspired 6.17% surge in that stock, especially as she is married to Gordon Gekko. Ahead of Saturday's Run for the Roses, Louisville's own Humana (HUM) jumped 4.66%.

The Garden State's Automatic Data Processing (ADP), based in Roseland, reached a new best even as it reported April private-sector jobs rose less than expected. Champagne socialists in France, complaining about austerity, celebrated the days of whine and roses by putting the Élysée Palace's prized cellars on the market. And in San Francisco - where they once put flowers in their hair - hometown hero Trulia (TRLA) gained 12.84% after finding free love among the analyst community.

We're now more than two-thirds of way through earnings season, but key results continue to roll in. Among today's standouts are American International Group (AIG), British Sky Broadcasting (PINK:BSYBY), General Motors (GM), Gilead Sciences (GILD), Kellogg (K), Kraft Foods (KRFT), LinkedIn (LNKD), Monster Worldwide (MWW), Royal Dutch Shell (RDS-A), and Sanofi-Aventis (SNY).

ION Geophysical (IO): Barrington begins Outperform rated research on IO.

Sucampo Pharmaceuticals (SCMP): The stock is begun with a Buy at MLV & Co, whose price objective is $14. Recent approval of Amitiza, used to treat conditions including chronic idiopathic constipation and irritable bowel syndrome, is a catalyst.

T-Mobile US (NYSE:TMUS): Shares, which surged 6.17% yesterday on their NYSE trading début after a bullish Buy initiation from Goldman Sachs (GS), are this morning assigned only a Hold at Argus.

(See also: Stock Upgrades: Comedy Central Owner Viacom Laughing All the Way to the Bank and Stock Downgrades: MasterCard No Longer Quite So 'Priceless.')
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
PrintPRINT

Busy? Subscribe to our free newsletter!

Submit
 

WHAT'S POPULAR IN THE VILLE